Polson Reports Flat Performance in Q2, Advised to Hold Stock by MarketsMOJO
Polson, a microcap chemical company, has reported a flat performance in the quarter ending June 2024, with a score of -2 compared to 2 in the previous quarter. The decline can be attributed to a decrease in net sales by -16.72% year on year. Despite this, Polson remains a strong player in the industry with a focus on innovation and quality. Investors are advised to hold their positions as the company works towards improving its financial performance.
Polson, a microcap chemical company, has recently announced its financial results for the quarter ending June 2024. The company's stock call has been declared as 'Hold' by MarketsMOJO, a leading financial analysis platform.
According to the financial report, Polson has seen a flat performance in the quarter, with a score of -2 compared to 2 in the previous quarter. This decline in score can be attributed to the decrease in net sales, which have fallen by -16.72% year on year. The company's near-term sales trend is also showing a negative trend.
Despite these challenges, Polson remains a strong player in the chemicals industry. With a focus on innovation and quality, the company has established a strong reputation in the market. However, the recent financial results indicate that there may be some areas that need improvement.
Investors and experts are advised to hold their positions on Polson's stock for now, as the company works towards improving its financial performance. With a solid foundation and a dedicated team, Polson is well-positioned to overcome these challenges and continue its growth in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
